As of May 24, 2025, Liquidia Corp (LQDA) reports a ROA (Return on Assets) of -56.69%.
ROA (Return on Assets) evaluates how effectively a company turns its assets into profits, showcasing resource utilization.
Historical Trend of Liquidia Corp's ROA (Return on Assets)
Over recent years, Liquidia Corp's ROA (Return on Assets) has shown a stable trend. The table below summarizes the historical values:
| Date | ROA (Return on Assets) |
|---|---|
| 2024-12-31 | -56.69% |
| 2023-12-31 | -66.53% |
| 2022-12-31 | -31.75% |
| 2021-12-31 | -36.91% |
| 2020-12-31 | -60.06% |
This steady improvement highlights how Liquidia Corp manages its efficiency in using assets to generate earnings over time.
Comparing Liquidia Corp's ROA (Return on Assets) to Peers
To better understand Liquidia Corp's position, it's useful to compare its ROA (Return on Assets) against industry peers. Below are selected comparisons:
| Company | ROA (Return on Assets) |
|---|---|
| Liquidia Corp (LQDA) | -56.69% |
| Elite Pharmaceuticals Inc (ELTP) | 24.04% |
| Zoetis Inc (ZTS) | 17.46% |
| Merck & Co Inc (MRK) | 14.62% |
| Eli Lilly and Co (LLY) | 13.45% |
| Johnson & Johnson (JNJ) | 7.81% |
Compared to its competitors, Liquidia Corp's ROA (Return on Assets) is about average compared to peers, indicating typical asset efficiency for the industry.